Machine learning platform generates novel COVID-19 antibody sequences for experimental testing
Monday, May 4, 2020 - 09:40
in Biology & Nature
Lawrence Livermore National Laboratory (LLNL) researchers have identified an initial set of therapeutic antibody sequences, designed in a few weeks using machine learning and supercomputing, aimed at binding and neutralizing SARS-CoV-2, the virus that causes COVID-19. The research team is performing experimental testing on the chosen antibody designs.